These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10317248)

  • 1. Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases.
    Wallis C
    Time; 1982 Oct; 120(15):76, 79. PubMed ID: 10317248
    [No Abstract]   [Full Text] [Related]  

  • 2. New drug development in the changing health care environment: a panel discussion.
    Flanagan A; Temple RJ; Wardell WM
    Ann N Y Acad Sci; 1981; 368():203-11. PubMed ID: 6942776
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of orphan products.
    FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406
    [No Abstract]   [Full Text] [Related]  

  • 4. Orphan Drug Act on congressional agenda.
    von Oehsen WH
    Physician Exec; 1989; 15(3):34-5. PubMed ID: 10313123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug shortage crisis resolution.
    Duffy E
    J Pharm Pract; 2012 Dec; 25(6):619-20. PubMed ID: 23222856
    [No Abstract]   [Full Text] [Related]  

  • 6. Orphan drugs: the question of products liability.
    Scharf SF
    Am J Law Med; 1985; 10(4):491-513. PubMed ID: 3911776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug shortages undergo more scrutiny by Congress.
    Thompson CA
    Am J Health Syst Pharm; 2012 Mar; 69(6):446, 448, 450. PubMed ID: 22382473
    [No Abstract]   [Full Text] [Related]  

  • 8. Generic Pharmaceutical Industry Association Orphan Drug Institute.
    Haddad W
    Prog Clin Biol Res; 1985; 197():41-5. PubMed ID: 4070298
    [No Abstract]   [Full Text] [Related]  

  • 9. ACP position papers: orphan drugs.
    Am Coll Physicians Obs; 1983 Jan; 3(1):1, 6, 17. PubMed ID: 10258503
    [No Abstract]   [Full Text] [Related]  

  • 10. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New rules for US drug reimbursement.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs bill to rein in profits.
    Gershon D
    Nature; 1994 Mar; 368(6470):381. PubMed ID: 8133874
    [No Abstract]   [Full Text] [Related]  

  • 13. [Orphan drugs--medications for patients with rare diseases].
    Thielke D; Thyssen JP; Hansen BJ
    Ugeskr Laeger; 2006 Jun; 168(23):2236-8. PubMed ID: 16768975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug shortages in the United States: a critical evaluation of root causes and the need for action.
    Gupta DK; Huang SM
    Clin Pharmacol Ther; 2013 Feb; 93(2):133-5. PubMed ID: 23337520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: More on "orphan" drugs.
    Lyle WH
    N Engl J Med; 1975 Apr; 292(15):813-4. PubMed ID: 1113808
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 17. When drugs are in short supply.
    Zurlinden J
    Nurs Spectr (Wash D C); 1999 Feb; 9(4):15-6. PubMed ID: 10542818
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives. Orphan Drug Act stumps lawmakers.
    Firshein J
    Faulkner Grays Med Health; 1990 Jun; 44(25):suppl 4 p.. PubMed ID: 10105023
    [No Abstract]   [Full Text] [Related]  

  • 19. Seizures of Canadian drugs rise as Congress, Customs spar.
    Carreyrou J
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
    [No Abstract]   [Full Text] [Related]  

  • 20. Rare diseases, orphan drugs, and orphaned patients.
    Scheindlin S
    Mol Interv; 2006 Aug; 6(4):186-91. PubMed ID: 16960139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.